© 2022 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
Endocrinology
In gestational diabetes, tighter glycemic targets could influence outcomes for mother and child
September 23, 2022
Results of the TARGET trial provide insight into the effects of tight glycemic targets versus less tight targets on maternal and perinatal outcomes among women with gestational diabetes.
Diabetes not associated with breastfeeding ability
September 09, 2022
Investigators found minimal difference between breastfeeding rates less than 1 week postpartum of women who had diabetes pre-pregnancy, gestational diabetes only, and no history of diabetes.
Obesity in adolescence could raise type 1 diabetes risk in adulthood
June 22, 2022
New research suggests adolescent obesity could increase risk of type 1 diabetes in young adulthood.
In pediatric type 1 diabetes, race, income, insurance remain barriers to insulin pump use
June 22, 2022
An analysis of the SEARCH for Youth in Diabetes details historic and contemporary disparities in insulin pump use for pediatric type 1 diabetes based on racial/ethnic background, household income, and insurance type.
Exposure to marijuana in utero tied to early life increased fat mass, glucose levels
April 04, 2022
An analysis of more than 100 mother-child pairs from Colorado found children with fetal exposure to cannabis had increased fat mass and fasting glucose levels compared to their counterparts without fetal exposure to cannabis.
When puberty arrives too early or too late
October 09, 2021
Puberty will happen for every child, but when it arrives early or is delayed both parent and child may be worried. A presentation at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition discussed typical reasons for both early and delayed pubertal development.
Examining the factors that lead to diabetic retinopathy in kids
September 29, 2021
With both type 1 and type 2 diabetes on the rise in children, it’s important to understand the factors that can lead to the development of diabetic retinopathy.
FDA approves BYDUREON BCise for treatment of type 2 diabetes
July 23, 2021
The US Food and Drug Administration (FDA) has approved the AstraZeneca once-weekly injectable therapy for use in children aged 10 to 17 years.
Diagnosing and treating neonatal hypoglycemia
June 28, 2021
A session at the virtual Scientific Sessions for the American Diabetes Association offered some best practices for the diagnosis and treatment of hypoglycemia.